2458 Federal Register / Vol. 86, No. 7 / Tuesday, January 12, 2021 / Notices 

Controlled substance Drug code Schedule 

Morphine .......................................................................................................................................................................... 9300 II 

The company plans to synthesize the 

above listed control substances for 

distribution to its customers. In 

reference to drug codes 7360 

(Marihuana) and 7370 

(Tetrahydrocannabinol), the company 

plans to bulk manufacture these drugs 

as synthetics. No other activity for these 

drug codes are authorized for this 

registration. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–00356 Filed 1–11–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–762] 

Importer of Controlled Substances 

Application: S&B Pharma LLC dba 

Norac Pharma 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: S&B Pharma LLC, dba: Norac 

Pharma has applied to be registered as 

an importer of basic class(es) of 

controlled substance(s). Refer to 

Supplemental Information listed below 

for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before February 11, 2021. Such 

persons may also file a written request 

for a hearing on the application on or 

before February 11, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All requests for a 

hearing should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on August 25, 2020, S&B 

Pharma LLC, dba: Norac Pharma, 405 

South Motor Avenue, Azusa, California 

91702, applied to be registered as an 

importer of the following basic class(es) 

of controlled substance(s): 

Controlled substance Drug 

code Schedule 

4-Anilino-N-phenethyl-4- 

piperidine (ANPP).

8333 II 

Tapentadol .................... 9780 II 

The company plans to import the 

listed controlled substances in bulk for 

the manufacture of controlled 

substances for distribution to its 

customers. No other activity for these 

drug codes is authorized for this 

registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–00326 Filed 1–11–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–764] 

Bulk Manufacturer of Controlled 

Substances Application: Siegfried 

USA, LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Siegfried USA, LLC has 

applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

Supplemental Information listed below 

for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before March 15, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

March 15, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on December 9, 2020, 

Siegfried USA, LLC, 33 Industrial Park 

Road, Pennsville, New Jersey 08070– 

3244, applied to be registered as an bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Gamma Hydroxybutyric 

Acid.

2010 I 

Amphetamine ............... 1100 II 

Methylphenidate ........... 1724 II 

Amobarbital .................. 2125 II 

Pentobarbital ................ 2270 II 

Secobarbital .................. 2315 II 

Codeine ........................ 9050 II 

Oxycodone ................... 9143 II 

Hydromorphone ............ 9150 II 

Hydrocodone ................ 9193 II 

Methadone .................... 9250 II 

Methadone intermediate 9254 II 

Morphine ....................... 9300 II 

Oripavine ...................... 9330 II 

Thebaine ....................... 9333 II 

Opium tincture .............. 9630 II 

Oxymorphone ............... 9652 II 

Tapentadol .................... 9780 II 

The company plans to bulk 

manufacture the listed controlled 

substances in bulk for sale to its 

customers. No other activities for these 

drug codes are authorized for this 

registration. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–00354 Filed 1–11–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–760] 

Bulk Manufacturer of Controlled 

Substances Application: Bulk 

Manufacturer of Marihuana: Natural 

Fulfillment LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 


khammond on DSKJM1Z7X2PROD with NOTICES